Press Release – New York, NY – January 14, 2021 – Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: “LEXX”), in a closing of an underwritten public …
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement
Press Release – New York, New York – May 7, 2020 - Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) in a private placement of common …